Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/4646
Title: Spectrum of neurodevelopmental disease associated with the GNAO1 guanosine triphosphate-binding region
Authors: Waugh, J. L.
Snyder, M.
Calvert, Sophie 
Scheffer, I. E.
Yang, E.
Lal, D.
Poduri, A.
Bodamer, O.
Kelly, M.
Park, M.
Mihalek, I.
Rochtus, A.
Gramm, M.
Pérez-Palma, E.
Axeen, E. T.
Hung, C. Y.
Olson, H.
Swanson, L.
Anselm, I.
Briere, L. C.
High, F. A.
Sweetser, D. A.
Kayani, S.
Issue Date: 2019
Source: Mar 60, (3), 2019, p. 406-418
Pages: 406-418
Journal: Epilepsia
Abstract: OBJECTIVE: To characterize the phenotypic spectrum associated with GNAO1 variants and establish genotype-protein structure-phenotype relationships. METHODS: We evaluated the phenotypes of 14 patients with GNAO1 variants, analyzed their variants for potential pathogenicity, and mapped them, along with those in the literature, on a three-dimensional structural protein model. RESULTS: The 14 patients in our cohort, including one sibling pair, had 13 distinct, heterozygous GNAO1 variants classified as pathogenic or likely pathogenic. We attributed the same variant in two siblings to parental mosaicism. Patients initially presented with seizures beginning in the first 3 months of life (8/14), developmental delay (4/14), hypotonia (1/14), or movement disorder (1/14). All patients had hypotonia and developmental delay ranging from mild to severe. Nine had epilepsy, and nine had movement disorders, including dystonia, ataxia, chorea, and dyskinesia. The 13 GNAO1 variants in our patients are predicted to result in amino acid substitutions or deletions in the GNAO1 guanosine triphosphate (GTP)-binding region, analogous to those in previous publications. Patients with variants affecting amino acids 207-221 had only movement disorder and hypotonia. Patients with variants affecting the C-terminal region had the mildest phenotypes. SIGNIFICANCE: GNAO1 encephalopathy most frequently presents with seizures beginning in the first 3 months of life. Concurrent movement disorders are also a prominent feature in the spectrum of GNAO1 encephalopathy. All variants affected the GTP-binding domain of GNAO1, highlighting the importance of this region for G-protein signaling and neurodevelopment.1528-1167Kelly, McKenna
Park, Meredith
Mihalek, Ivana
Rochtus, Anne
Gramm, Marie
Pérez-Palma, Eduardo
Axeen, Erika Takle
Hung, Christina Y
Olson, Heather
Swanson, Lindsay
Anselm, Irina
Briere, Lauren C
High, Frances A
Sweetser, David A
Undiagnosed Diseases Network
Kayani, Saima
Snyder, Molly
Calvert, Sophie
Scheffer, Ingrid E
Yang, Edward
Waugh, Jeff L
Lal, Dennis
Bodamer, Olaf
Poduri, Annapurna
U01 HG007690/HG/NHGRI NIH HHS/United States
U01HG007690/GF/NIH HHS/United States
Fulbright Association/International
Bureau of Educational and Cultural Affairs of the United States Department of State and administered by the Institute of International Education/International
Boston Children's Hospital/International
K23 NS107646/NS/NINDS NIH HHS/United States
Australian National Health and Medical Research Council Program Grant and Practitioner Fellowship/International
U01 HG007942/HG/NHGRI NIH HHS/United States
U01HG007942/GF/NIH HHS/United States
Belgian American Educational Foundation/International
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Epilepsia. 2019 Mar;60(3):406-418. doi: 10.1111/epi.14653. Epub 2019 Jan 25.
DOI: 10.1111/epi.14653
Keywords: Genetic Association Studies;Genetic Predisposition to Disease;Genetic Variation;Neurodevelopmental Disorders;GNAO1;Epilepsy;Child, Preschool;Child;Adolescent
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

58
checked on Mar 25, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.